Zhu-fang Shen Selected Research

2- ethoxy- 3- (4- (2- (4- trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid

2/2008

Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhu-fang Shen Research Topics

Disease

9	Insulin Resistance 01/2014 - 12/2003
5	Type 2 Diabetes Mellitus (MODY) 03/2015 - 02/2008
4	Body Weight (Weight, Body) 01/2014 - 02/2002
3	Glucose Intolerance 01/2014 - 11/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2010 - 02/2008
2	Obesity 01/2010 - 05/2005
1	Prediabetic State (Prediabetes) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2011
1	Hyperlipidemias (Hyperlipidemia) 04/2011
1	Dyslipidemias (Dyslipidemia) 04/2011
1	Insulinoma 02/2010
1	Inflammation (Inflammations) 01/2010
1	Alzheimer Disease (Alzheimer's Disease) 12/2007
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2007
1	Hyperinsulinism (Hyperinsulinemia) 05/2005
1	Hyperglycemia 02/2002

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 12/2003
8	Insulin (Novolin)FDA Link 01/2014 - 12/2003
5	LipidsIBA 03/2015 - 02/2002
4	CholesterolIBA 01/2014 - 02/2008
4	Triglycerides (Triacylglycerol)IBA 02/2013 - 02/2008
4	Sodium Glutamate (Accent)IBA 10/2011 - 12/2003
3	Nonesterified Fatty Acids (NEFA)IBA 04/2011 - 02/2008
2	Blood Glucose (Blood Sugar)IBA 01/2014 - 11/2012
2	Fenofibrate (CiL)FDA LinkGeneric 10/2011 - 04/2011
2	Atorvastatin (Lipitor)FDA Link 04/2011 - 01/2010
2	GlycogenIBA 02/2008 - 12/2007
2	Rosiglitazone (Avandia)FDA Link 02/2008 - 12/2003
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2014
1	TabletsIBA 01/2014
1	JinqiIBA 01/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	BerberineIBA 11/2012
1	PPAR alphaIBA 04/2011
1	Poloxamer (Poloxamer 407)IBA 04/2011
1	EnzymesIBA 04/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2011
1	Cholesterol Esters (Cholesteryl Esters)IBA 04/2011
1	Apolipoproteins B (ApoB)IBA 04/2011
1	Exenatide (Byetta)FDA Link 02/2010
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2010
1	Glutamic Acid (Glutamate)FDA Link 02/2010
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2010
1	IncretinsIBA 02/2010
1	oxidized low density lipoproteinIBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	2- ethoxy- 3- (4- (2- (4- trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acidIBA 02/2008
1	Alanine (L-Alanine)FDA Link 02/2008
1	Glycogen Synthase Kinase 3IBA 12/2007
1	Sucrose (Saccharose)IBA 05/2005
1	PPAR-gamma AgonistsIBA 05/2005
1	Pioglitazone (Actos)FDA Link 05/2005
1	Glucose Transporter Type 4IBA 05/2005
1	Streptozocin (Streptozotocin)FDA Link 05/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2003
1	Conjugated Linoleic AcidsIBA 12/2003
1	AlloxanIBA 02/2002
1	Acetylglucosaminidase (NAGase)IBA 02/2002
1	Glycoside Hydrolase InhibitorsIBA 02/2002

Therapy/Procedure

2	Therapeutics 01/2010 - 02/2008
1	Subcutaneous Injections 02/2010